NantHealth, Inc. operates as an evidence-based, personalized healthcare company, which provides treatment for critical diseases such as cancer. It is based on personalized healthcare approach that integrates novel diagnostics with large scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Culver City, CA.
SHORT INTEREST
1.4M 08/30/19
P/E Current
-0.45
P/E Ratio (with extraordinary items)
-0.48
Average Recommendation: BUY
Average Target Price:
SHORT INTEREST
1.4M 08/30/19
P/E Current
-0.45
P/E Ratio (with extraordinary items)
-0.48
Average Recommendation: BUY
Average Target Price:
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media